Lazard Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.41M | Buy |
386,011
+11,928
| +3% | +$167K | 0.01% | 711 |
|
|
2025
Q1 | $5.85M | Sell |
374,083
-14,230
| -4% | -$223K | 0.01% | 633 |
|
|
2024
Q4 | $5.41M | Sell |
388,313
-414,891
| -52% | -$5.78M | 0.01% | 622 |
|
|
2024
Q3 | $7.47M | Buy |
803,204
+443,207
| +123% | +$4.12M | 0.01% | 533 |
|
|
2024
Q2 | $3.35M | Buy |
+359,997
| New | +$3.35M | ﹤0.01% | 771 |
|